| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |